Becton Dickinson Price to Sales Ratio 2010-2024 | BDX
Historical PS ratio values for Becton Dickinson (BDX) over the last 10 years. The current P/S ratio for Becton Dickinson as of November 07, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Becton Dickinson P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2024-11-06 |
240.06 |
|
3.51 |
| 2024-06-30 |
232.78 |
$68.36 |
3.41 |
| 2024-03-31 |
245.49 |
$68.11 |
3.60 |
| 2023-12-31 |
240.93 |
$67.61 |
3.56 |
| 2023-09-30 |
254.43 |
$67.53 |
3.77 |
| 2023-06-30 |
258.94 |
$66.46 |
3.90 |
| 2023-03-31 |
241.90 |
$65.67 |
3.68 |
| 2022-12-31 |
247.54 |
$65.33 |
3.79 |
| 2022-09-30 |
216.11 |
$65.71 |
3.29 |
| 2022-06-30 |
238.30 |
$63.87 |
3.73 |
| 2022-03-31 |
249.90 |
$63.50 |
3.94 |
| 2021-12-31 |
235.49 |
$63.68 |
3.70 |
| 2021-09-30 |
229.38 |
$65.36 |
3.51 |
| 2021-06-30 |
226.21 |
$63.88 |
3.54 |
| 2021-03-31 |
225.39 |
$61.62 |
3.66 |
| 2020-12-31 |
231.15 |
$60.36 |
3.83 |
| 2020-09-30 |
214.21 |
$58.92 |
3.64 |
| 2020-06-30 |
219.53 |
$61.53 |
3.57 |
| 2020-03-31 |
210.15 |
$63.55 |
3.31 |
| 2019-09-30 |
229.86 |
$63.25 |
3.63 |
| 2019-06-30 |
228.33 |
$63.21 |
3.61 |
| 2019-03-31 |
225.53 |
$62.72 |
3.60 |
| 2018-12-31 |
202.85 |
$62.79 |
3.23 |
| 2018-09-30 |
234.20 |
$63.42 |
3.69 |
| 2019-12-31 |
247.89 |
$60.17 |
4.12 |
| 2018-06-30 |
214.34 |
$58.96 |
3.64 |
| 2018-03-31 |
193.25 |
$57.09 |
3.38 |
| 2017-12-31 |
190.26 |
$54.93 |
3.46 |
| 2017-09-30 |
173.57 |
$54.96 |
3.16 |
| 2017-06-30 |
172.19 |
$55.65 |
3.09 |
| 2017-03-31 |
161.28 |
$56.62 |
2.85 |
| 2016-12-31 |
144.98 |
$57.15 |
2.54 |
| 2016-09-30 |
156.70 |
$57.54 |
2.72 |
| 2016-06-30 |
147.31 |
$57.43 |
2.57 |
| 2016-03-31 |
131.36 |
$57.23 |
2.30 |
| 2015-12-31 |
132.73 |
$53.33 |
2.49 |
| 2015-09-30 |
113.78 |
$49.93 |
2.28 |
| 2015-06-30 |
120.95 |
$46.32 |
2.61 |
| 2015-03-31 |
122.09 |
$42.76 |
2.86 |
| 2014-12-31 |
117.83 |
$42.99 |
2.74 |
| 2014-09-30 |
95.96 |
$42.75 |
2.24 |
| 2014-06-30 |
99.28 |
$42.16 |
2.35 |
| 2014-03-31 |
97.80 |
$41.54 |
2.35 |
| 2013-12-31 |
91.86 |
$41.14 |
2.23 |
| 2013-09-30 |
82.74 |
$40.49 |
2.04 |
| 2013-06-30 |
81.35 |
$39.35 |
2.07 |
| 2013-03-31 |
78.30 |
$38.66 |
2.03 |
| 2012-12-31 |
63.68 |
$37.76 |
1.69 |
| 2012-09-30 |
63.57 |
$36.66 |
1.73 |
| 2012-06-30 |
60.13 |
$35.51 |
1.69 |
| 2012-03-31 |
62.08 |
$34.60 |
1.79 |
| 2011-12-31 |
59.39 |
$33.93 |
1.75 |
| 2011-09-30 |
57.91 |
$33.42 |
1.73 |
| 2011-06-30 |
67.72 |
$31.93 |
2.12 |
| 2011-03-31 |
62.27 |
$30.88 |
2.02 |
| 2010-12-31 |
65.76 |
$29.83 |
2.20 |
| 2010-09-30 |
57.37 |
$29.61 |
1.94 |
| 2010-06-30 |
52.07 |
$29.83 |
1.75 |
| 2010-03-31 |
60.31 |
$29.55 |
2.04 |
| 2009-12-31 |
60.12 |
$29.10 |
2.07 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$69.388B |
$19.372B |
|
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
|
